Apheresis equipment market is expected to grow over the forecast period owing to the increasing prevalence of hemophilia, sickle cell anemia, blood cancer and rising demand for blood products. The other growth drivers of this market are lifestyle induced diseases such as obesity & diabetes, sophisticated healthcare infrastructure, increasing geriatric population and awareness. These factors are expected to drive the market over the forecast period. Apheresis is process in which blood passes through an apparatus and the components of the blood get separated. The targeted components are separated and remaining components are returned to the circulation. For this whole procedure medical technology and extracorporeal therapy are used. The components which are extracted from the blood units are leukocytes, plasma and platelets. With the help of therapeutic apheresis, the components which are contributing towards diseases are removed from the blood. Stem cell harvesting, leukopheresis, plateletpheresis and plasmapheresis are the few examples of the disease inducing blood components. Familial hypercholesterolemia or FH is one of the examples of genetic disorders. It is further characterization into bad cholesterol LDL on the basis of high cholesterol. LDL-apheresis application is used for those patients who are not responding to regular medical treatment and patient suffering from rhabdomyolysis or breakdown of coronary heart disorder. Apheresis equipment is widely used for the blood with high in cholesterol. The other factor which is anticipated to drive the market over the forecast period are rising incidences of chronic diseases such as cancer and autoimmune diseases, favorable reimbursement policies, biopharmaceutical companies incresing demand for plasma, sophisticated healthcare infrastructure in developing economies, and increase in number of platelet donors.
Apheresis equipment market is segmented on the basis of product types into disposables, and devices. Among these, devices held the largest market share in 2013 in terms of revenue, as these devices prices are very high. Disposable medical devices usages rate is growing as it prevents infections such as bloodstream and it also slows down the incidence or cases rates of hospital acquired infections. Over the forecast period, apheresis equipment market is expected to grow at a faster rate.
Apheresis equipment market is segmented on the basis of application into neurology, hematology, and renal diseases. Among these, neurology application held the largest market share in 2013, due to the rising plasma exchange coupled with majority of multiple sclerosis is increasing in U.S. Over the upcoming five years this application is expected to show fruitful CAGR.
Apheresis equipment market is segmented on the basis of procedure into erythrocytapheresis, photophereis, leukapheresis, plateletpheresis, LDL-apheresis, and plasmapheresis. Among these, plateletpheresis held the largest market share in 2013, owing to its uses in donor apheresis area, and its applicability is widespread. Photopheresis is the fastest growing procedure in 2013, as die to rising rate of graft versus host disease and scleroderma. Scleroderma mostly affects women four times more than man and it describes syndrome of dermatitis, enteritis, hepatitis and transplanted solid organs having a risk of chronic GVHD having unirradiated blood products, and lymphoid tissues. Over the forecast period plateletpheresis segment will witness lucrative growth rate.
Apheresis equipment market is segmented on the basis of technology into membrane centrifugation & filtration. Among these, centrifugation held the largest segment in 2013 owing to its use in apheresis of any of the blood components. Where-as, membrane technology is only restricted to plasma exchange.
Geographically, the Apheresis equipment market is studied with respect to four regions such as Asia Pacific, Europe, North America, and RoW. Among these, North America is dominating the whole market in 2013, as it has presence of technologically updated systems, strong research & development, various government initiatives & programs and high patient awareness levels in this region. The growing economies in Asia Pacific such as India and China region are expected to witness lucrative growth over the forecast period owing to the rising healthcare expenditure, and awareness about the hospital acquired infection.
The major market players in the apheresis equipment market are Kawasumi Laboratories Inc., Hemacare Corporation, B. Braun Melsungen AG, Therakos Inc., Haemonetics Corp., Fenwal Inc., Terumo BCT Inc., and Asahi Kasei Kuraray Medical Co Ltd.
Research Support Specialist, USA